Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Fitbit eyes pharma partnerships with digital health hire

Taps Walgreens Boots Alliance's Adam Pellegrini to build industry relationships

Fitbit wearable fitness tracker 

Fitbit is ramping up its efforts to strike deals with pharmaceutical companies and other healthcare players, such as payers, insurers and medical device firms. 

To assist its push the fitness wearables company has appointed new VP of digital health Adam Pellegrini, who will also be tasked with helping Fitbit connect its products into clinical settings. 

Wearables are being investigated by pharma companies such as UCB's Parkinson's trial and work by GlaxoSmithKline in neurodegenerative condition ALS, and Fitbit is keen to tap into this interest.

Pellgerini will join Fitbit on September 6 from Walgreens Boots Alliance, where his responsibilities as digital health VP included advancing the company's integration with wearables. 

Fitbit said he will also work on creating “better clinical health outcomes” and increasing its participation in disease management, insurance, and wellness programmes.

Pellegrini said: “I'm a passionate believer in the power of digital health technology to improve the effectiveness, efficiency and reach of our healthcare system. I see a tremendous opportunity for healthcare providers, health plans and pharmaceutical companies to foster a more proactive, consumer-centric approach to healthcare using Fitbit's products, software, services and extraordinary health brand.”

Pellegrini brings more than 20 years of experience from a number of healthcare sectors, including health technology and insurance. 

During his time at Walgreens, his team launched the company's first integration of wearables - including Fitbit devices - with its Balance Rewards programme, which rewards customers for making healthy choices.

12th August 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics